Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 213,300 | 171,200 | 451,100 | 468,200 | 433,800 |
| Marketable Securities | 196,200 | 279,300 | N/A | N/A | N/A |
| Receivables | 346,700 | 320,700 | 346,800 | 364,100 | 354,200 |
| Inventories | 268,300 | 261,300 | 247,900 | 229,400 | 217,700 |
| Income taxes - deferred | 31,600 | 43,900 | 25,300 | 57,800 | 56,000 |
| Other current assets | 90,200 | 57,100 | 67,800 | 53,300 | 45,900 |
| TOTAL | $1,188,000 | $1,168,500 | $1,181,900 | $1,216,800 | $1,150,300 |
| Non-Current Assets | |||||
| PPE Net | 308,200 | 304,300 | 286,400 | 281,000 | 274,300 |
| Investments And Advances | 21,900 | 21,800 | 21,400 | 24,800 | 27,300 |
| Intangibles | 414,900 | 416,700 | 420,000 | 422,800 | 426,200 |
| Other Non-Current Assets | 71,200 | 69,200 | 73,200 | 57,000 | 53,000 |
| TOTAL | $816,200 | $812,000 | $801,000 | $785,600 | $780,800 |
| Total Assets | $2,004,200 | $1,980,500 | $1,982,900 | $2,002,400 | $1,931,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 149,500 |
| Accounts payable and accrued liabilities | 265,200 | 85,000 | 302,000 | 313,300 | 295,700 |
| Accrued Expenses | N/A | 234,800 | N/A | N/A | N/A |
| TOTAL | $265,200 | $335,200 | $302,000 | $313,300 | $445,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 179,400 | 150,400 | 175,000 | 174,800 | N/A |
| Other Non-Current Liabilities | 169,300 | 157,000 | 151,300 | 129,100 | 128,100 |
| TOTAL | $348,700 | $307,400 | $326,300 | $303,900 | $128,100 |
| Total Liabilities | $613,900 | $642,600 | $628,300 | $617,200 | $573,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 687,593 | 689,883 | 684,451 | 689,731 | 688,075 |
| Common Shares | 121,100 | 120,000 | 119,500 | 118,800 | 117,700 |
| Retained earnings | 1,425,800 | 1,360,700 | 1,297,600 | 1,246,000 | 1,187,900 |
| Other shareholders' equity | -24,900 | -37,300 | -23,000 | -9,000 | -15,800 |
| TOTAL | $1,390,300 | $1,337,900 | $1,354,600 | $1,385,200 | $1,357,800 |
| Total Liabilities And Equity | $2,004,200 | $1,980,500 | $1,982,900 | $2,002,400 | $1,931,100 |